| Literature DB >> 34874966 |
Kalpesh Narsi1, Andrew Tomita2,3, Suvira Ramlall1.
Abstract
Despite lower incidences of HIV-associated dementia due to antiretroviral therapy, neuropsychological impairment (NPI) remains a persistent challenge in sub-Saharan Africa. Improving cognitive reserve (CR) can mitigate NPI, but there are few investigations on neuropsychological (NP) performance, and its association with CR in newly diagnosed ART-naïve HIV-positive individuals to inform early treatment strategies. A comprehensive battery of tests were administered to assess various NP domains (International HIV Dementia Scale [for memory, motor speed, psychomotor speed], Digit Span Test [for attention], Action Fluency Test [for language] and Clock Drawing Test [for executive/visuospatial function]), and CR (using Cognitive Reserve Index Questionnaire) among 211 newly diagnosed ART-naïve HIV-positive participants from two clinics that serve peri-urban and informal settlement communities in KwaZulu-Natal, South Africa. Regression models were fitted to assess the association between NP performance and CR controlling for socioeconomic and clinical factors. Test results revealed high levels of impairment across NP domains: language (96.7%), memory and psychomotor speed (82.5%), concentration (17.5%), executive function (15.2%) and visuo-spatial function (3.3%). Low CR and educational attainment were the only factors consistently associated with poor NP performance based on regression. High levels of impairment were found in certain NP domains in a relatively young group of newly diagnosed ART-naïve HIV-positive individuals. Residents of peri-urban and informal settlements face multitude of complex challenges in South Africa. An early multilevel intervention targeting clinical- (e.g. CR) and structural-level challenges (e.g. access to education) is needed for mitigating HIV-associated NPI and promoting long-term healthy living.Entities:
Mesh:
Year: 2021 PMID: 34874966 PMCID: PMC8651099 DOI: 10.1371/journal.pone.0260260
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Profile of neuropsychological tests used: Psychometric profile of tests.
| Test | Neurocognitive domains tested | Cut-off | Sensitivity | Specificity | Validation |
|---|---|---|---|---|---|
| IHDS | Memory | ≤10 | 62 | 76 | South African HIV positive cohort [ |
| Motor speed | |||||
| Psychomotor speed | |||||
| DSF | Attention | <5 | 42 | 93 | South African HIV positive cohort [ |
| DSB | <3 | ||||
| AFT | Language | <15 | 76 | 84 | HIV positive cohort [ |
| CDT | Executive function (CLOX1) | <10 | 77 | 90 | HIV positive cohort [ |
| Visuospatial function (CLOX2) | <12 |
IHDS, International HIV Dementia Scale; DSF, Digit Span-Forward; DSB, Digit Span-Backward; AFT, Action Fluency Test; CDT, Clock Drawing Test.
Sociodemographic and clinical profile stratified by Cognitive Reserve Index (CRI) with p-values from univariate analysis.
| Variable | Category | CRI category | Total | p-value | |
|---|---|---|---|---|---|
| Low-medium | Medium | ||||
| n, (%) | n, (%) | ||||
| Age | M = 29 | M = 31 | |||
| 18–29 years | 60 (54.5) | 50 (45.4) | 110 | 0.74 | |
| 30–39 years | 39 (52.0) | 36 (48.0) | 75 | ||
| ≥ 40 years | 12 (46.2) | 14 (53.8) | 26 | ||
| Gender | Females | 83 (55.7) | 66 (44.3) | 149 | 0.16 |
| Males | 28 (45.2) | 34 (54.8) | 62 | ||
| Marital status | Single / Widowed | 90 (52.0) | 83 (48.0) | 173 | 0.72 |
| Married / Co-habiting | 21 (55.3) | 17 (44.7) | 38 | ||
| Educational attainment | ≤ Grade 7 | 23 (100) | 0 (0) | 23 | <0.01 |
| Grade 8–11 | 61 (64.2) | 34 (35.8) | 95 | ||
| ≥ Grade 12 | 27 (29.0) | 66 (71.0) | 93 | ||
| Employment status | Employed—formal sector | 24 (60.0) | 16 (40.0) | 40 | 0.52 |
| Employed—Informal sector | 31 (48.4) | 33 (51.6) | 64 | ||
| Unemployed | 56 (52.3) | 51 (47.7) | 107 | ||
| Substance Use (any) | No Substance Use | 52 (54.7) | 43 (45.3) | 95 | 0.58 |
| Substance Use (any) | 59 (50.9) | 57 (49.1) | 116 | ||
| Comorbid chronic illness | No | 98 (53.0) | 87 (47.0) | 185 | 0.78 |
| Yes | 13 (50) | 13 (50) | 26 | ||
| Depression status | Not depressed | 99 (53.2) | 87 (46.8) | 186 | 0.62 |
| Major depressive disorder | 12 (48.0) | 13 (52.0) | 25 | ||
| Suspected duration of HIV infection | Infection not suspected at time of testing | 70 (54.7) | 58 (45.3) | 128 | 0.63 |
| Suspected infection in last 12 months | 28 (51.9) | 26 (48.1) | 54 | ||
| Suspected infection for > 12 months | 13 (44.8) | 16 (55.2) | 29 | ||
| CD4 count (n = 205) | M = 401 | M = 422 | |||
| < 200 | 27 (58.7) | 19 (41.3) | 46 | 0.52 | |
| 200–499 | 50 (53.2) | 44 (46.8) | 94 | ||
| ≥ 500 | 31 (47.7) | 34 (52.3) | 65 | ||
CRI, Cognitive Reserve Index.
a Cognitive Reserve Index Questionnaire (CRIq) score: 70–84;
b CRIq score: 85–114.
Performance on neuropsychological tests.
| Cognitive domain | Test | Mean | Range | SD | Cut off value | Below cut-off | Above cut-off |
|---|---|---|---|---|---|---|---|
| n (%) | n (%) | ||||||
| Psychomotor speed and memory | IHDS Total | 8.42 | 3–12 | 1.96 | ≤ 10 | 174 (82.5) | 37 (17.5) |
| Motor speed | 2.9 | 1–4 | 0.79 | ||||
| psychomotor speed | 2.5 | 0–4 | 1.11 | ||||
| Memory | 3.03 | 0–4 | 1.01 | ||||
| Attention and Concentration | DSF | 5.18 | 3–8 | 0.98 | <5 | 3 (1.4) | 208 (98.6) |
| DSB | 3.27 | 2–6 | 0.85 | <3 | 38 (18) | 173 (82) | |
| Language | AFT | 8.67 | 3–19 | 2.69 | <15 | 194 (96.7) | 7(3.3) |
| Executive Function | CDT—CLOX1 | 11.9 | 4–15 | 2.32 | <10 | 32 (15.2) | 179 (84.8) |
| Visuospatial Function | CDT—CLOX2 | 13.9 | 4–15 | 1.31 | <12 | 7 (3.3) | 203 (97.7) |
IHDS, International HIV Dementia Scale; DSF, Digit Span-Forward; DSB, Digit Span-Backward; AFT, Action Fluency Test; CDT, Clock Drawing Test.
Regression model investigating adjusted associations between socio-demographic and clinical factors and neuropsychological performance.
| Socio-demographic clinical predictors | Reference | Variables | Composite Cognitive Score | IHDS | DSF | DSB | AFT | CLOX1 | CLOX2 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B | SE | p | B | SE | p | B | SE | p | B | SE | p | B | SE | p | B | SE | p | B | SE | p | |||
| Gender | Female | Male | -0.72 | 0.54 | 0.19 | -0.32 | 0.28 | 0.25 | -0.19 | 0.16 | 0.24 | -0.05 | 0.14 | 0.71 | -0.04 | 0.40 | 0.92 | -0.12 | 0.37 | 0.75 | -0.30 | 0.22 | 0.16 |
| Age category | 18–29 years | 30–39 | -0.59 | 0.52 | 0.26 | -0.79 | 0.28 |
| 0.10 | 0.15 | 0.50 | -0.03 | 0.13 | 0.84 | -0.38 | 0.39 | 0.33 | -0.32 | 0.37 | 0.38 | 0.03 | 0.21 | 0.88 |
| 40+ | -0.88 | 0.78 | 0.26 | -0.92 | 0.41 |
| 0.05 | 0.23 | 0.84 | -0.07 | 0.20 | 0.72 | -0.27 | 0.58 | 0.64 | -0.72 | 0.55 | 0.19 | 0.04 | 0.32 | 0.89 | ||
| Educational attainment | < = Grade 7 | Grade 8–11 | 2.31 | 0.81 |
| 0.66 | 0.42 | 0.12 | 0.55 | 0.23 |
| 0.41 | 0.20 |
| -0.79 | 0.60 | 0.19 | 1.61 | 0.56 |
| 0.68 | 0.33 |
|
| Grade 12+ | 2.88 | 0.88 |
| 0.36 | 0.46 | 0.43 | 0.70 | 0.25 |
| 0.53 | 0.22 |
| 0.38 | 0.65 | 0.56 | 1.86 | 0.61 |
| 0.55 | 0.36 | 0.12 | ||
| Employment status | Unemployed | Formal sector | -0.33 | 0.66 | 0.62 | -0.33 | 0.35 | 0.35 | -0.09 | 0.20 | 0.63 | 0.01 | 0.17 | 0.97 | -0.94 | 0.50 | 0.06 | 0.20 | 0.47 | 0.66 | 0.24 | 0.27 | 0.37 |
| Informal sector | -0.14 | 0.61 | 0.82 | -0.01 | 0.32 | 0.97 | -0.17 | 0.18 | 0.35 | -0.03 | 0.16 | 0.87 | -0.21 | 0.46 | 0.65 | 0.23 | 0.43 | 0.59 | 0.06 | 0.25 | 0.80 | ||
| Substance Use | No | Yes | 0.66 | 0.46 | 0.15 | 0.60 | 0.24 |
| 0.04 | 0.14 | 0.76 | 0.20 | 0.12 | 0.08 | -0.01 | 0.34 | 0.98 | 0.15 | 0.32 | 0.65 | 0.01 | 0.19 | 0.95 |
| Comorbid chronic illness | No | Yes | 0.46 | 0.70 | 0.52 | 0.91 | 0.37 |
| 0.12 | 0.21 | 0.57 | 0.04 | 0.18 | 0.84 | -1.53 | 0.53 |
| 0.11 | 0.49 | 0.83 | 0.46 | 0.28 | 0.11 |
| Significant Head injury | No | Yes | -1.03 | 0.97 | 0.29 | -1.24 | 0.51 |
| -0.16 | 0.29 | 0.59 | -0.36 | 0.25 | 0.15 | -0.12 | 0.73 | 0.87 | 0.14 | 0.68 | 0.83 | 0.22 | 0.39 | 0.57 |
| Depression Status | No MDD | MDD | 0.37 | 0.68 | 0.58 | 0.03 | 0.36 | 0.93 | 0.02 | 0.20 | 0.93 | -0.20 | 0.17 | 0.25 | 0.30 | 0.51 | 0.55 | 0.54 | 0.47 | 0.25 | 0.29 | 0.27 | 0.29 |
| CRIq score | 70–84 | 85–114 | 2.40 | 0.50 |
| 1.42 | 0.27 |
| 0.20 | 0.15 | 0.17 | 0.32 | 0.13 |
| 1.41 | 0.38 |
| 0.59 | 0.35 | 0.09 | 0.41 | 0.20 |
|
| Suspected Infection duration | Infection not suspected | Infected ≤12 months | 0.13 | 0.53 | 0.80 | 0.18 | 0.28 | 0.52 | 0.05 | 0.16 | 0.77 | -0.07 | 0.13 | 0.58 | 0.07 | 0.40 | 0.87 | 0.02 | 0.37 | 0.95 | 0.06 | 0.21 | 0.79 |
| Infected > 12 months | -0.14 | 0.69 | 0.84 | 0.16 | 0.37 | 0.67 | -0.05 | 0.20 | 0.81 | 0.00 | 0.17 | 0.98 | 1.02 | 0.52 | 0.05 | -0.51 | 0.48 | 0.30 | -0.44 | 0.28 | 0.12 | ||
| CD4 category | <200 | 200–499 | 0.60 | 0.58 | 0.30 | 0.61 | 0.31 |
| -0.01 | 0.17 | 0.97 | 0.18 | 0.15 | 0.23 | 0.50 | 0.43 | 0.25 | -0.14 | 0.41 | 0.73 | -0.04 | 0.23 | 0.85 |
| 500+ | 0.06 | 0.64 | 0.92 | 0.04 | 0.34 | 0.90 | -0.10 | 0.19 | 0.61 | -0.05 | 0.16 | 0.77 | 1.00 | 0.48 |
| -0.21 | 0.45 | 0.64 | -0.11 | 0.26 | 0.67 | ||
IHDS, International HIV Dementia Scale; DSF, Digit Span-Forward; DSB, Digit Span-Backward; AFT, Action Fluency Test; CLOX1, Clock Drawing Test—executive function score; CLOX2, Clock Drawing Test—visuospatial function score; MDD, major depressive disorder; CRIq, Cognitive Reserve Index Questionnaire.
Fig 1Box and whisker plot of averaged neuropsychological test performance z scores according to Cognitive Reserve Index categories.